BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, March 14, 2026
Home » Topics » Science » Targeted therapy

Targeted therapy
Targeted therapy RSS Feed RSS

Cancer

Novel organo-arsenic compound suppresses osteosarcoma growth by inhibiting PDK-1

Feb. 2, 2023
Researchers from Zhongnan Hospital of Wuhan University reported data from a study that aimed to evaluate the therapeutic efficiency of organic arsenic compounds for the treatment of osteosarcoma.
Read More
Breast cancer illustration
Cancer

CREB1 inhibition reverses mammary tumor growth caused by Cullin-5 deficiency

Jan. 31, 2023
Breast cancer-associated gene 1 (BRCA1) is a critical tumor suppressor in breast cancer, and BRCA1 deficiency impairs DNA damage repair, leading to DNA damage accumulation and subsequent genetic alterations that result in the onset of breast cancer. In the current study, researchers from the University of Macau aimed to identify the potential factors that may participate in BRCA1-associated tumorigenesis.
Read More
Liver anatomy illustration
Gastrointestinal

CLDN1 is a therapeutic target in primary sclerosing cholangitis

Nov. 22, 2022
Primary sclerosing cholangitis (PSC) is a disease affecting the bile ducts that can lead to end-stage liver disease and cholangiocarcinoma. Patients with this disease lack therapeutic treatment other than liver transplantation.
Read More
Brain and encephalography
Neurology/Psychiatric

CACNB3 as novel therapeutic target in mesial temporal lobe epilepsy

Nov. 17, 2022
Investigators at the University of Copenhagen and affiliated organizations presented data from a study that aimed to validate differentially expressed genes (DEGs) in mesial temporal lobe epilepsy (mTLE) as potential new targets.
Read More
Immune

Targeting Stk4 alters Treg cell function relevant to cancer immunotherapy and autoimmunity

Oct. 26, 2022
Regulatory T (Treg) cells play a key role in peripheral tolerance and they prevent immune dysregulation as well as promote tissue...
Read More
Cancer

BATF as key epigenetic regulator of human Treg cells in the TME

Oct. 20, 2022
Regulatory T (Treg) cells represent promising targets in cancer immunotherapy...
Read More
Serotonin molecule
Cancer

Serotonin-targeting agents as potential therapeutic option for long-term control of tumors

Oct. 4, 2022
Researchers from University Hospital and University of Zürich aimed to assess the effects of serotonin on the tumor microenvironment.
Read More
Concept art for blood sugar.
Endocrine/Metabolic

α-MSH, a newly identified regulator of glycemia in human physiology

Sep. 28, 2022
Researchers from University College Dublin and affiliated organizations presented data from a study that aimed to assess the role of α-melanocyte-stimulatory hormone (α-MSH) in diabetes.
Read More
Cancer cell and DNA
Cancer

IL-27 gene signature is enriched for IFN‑stimulated genes associated with cancer therapy resistance

Sep. 27, 2022
Scientists at Surface Oncology Inc. described data from a study that aimed to evaluate the role of IL-27, a heterodimeric cytokine that plays a role in controlling the intensity and duration of immune system responses, in cancer therapy resistance.
Read More
Lung cancer illustration
Cancer

Targeting BMPR2 is an approach to treat lung cancer

Sep. 22, 2022
Researchers have designed a 3D model of lung cancer that is composed of bronchial epithelial, fibroblasts, epithelial, lung adenocarcinoma and immune cells grown in different layers in a matrigel.
Read More
Previous 1 2 3 4 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 13, 2026.
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent

    BioWorld Science
    Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing